Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment.

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

A 2-item food security instrument captures similar mortality risk information as instruments with more items among adults in the US.

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

HealthDay News — The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions ...

The CDC has not only lost nearly a fifth of its workforce, it has also been directed to slash $2.9 billion in contract spending.

Cervical artery dissection incidence increased from 2005 to 2019, with admissions particularly high in older, Black, and Hispanic populations.

Researchers have found that patients with stage B heart failure characteristics and type 2 diabetes have impaired functional capacity.

Researchers determined patients with paroxysmal hemoglobinuria may benefit from receiving ravulizumab over the long term.

For patients with OHCA, a critical factor in determining survival and long-term outcomes is how quickly CPR is initiated.